July 23 (Reuters) - Moderna's Covid-19 vaccine could become the second shot okayed for adolescent use in the European Union after regulators on Friday recommended approving it for 12- to 17-year-olds ahead of U.S. authorities. Moderna in May said its vaccine was found to be safe and effective in teenagers. The regulator said common side effects in teenagers after vaccination with Spikevax were similar to those seen in older people. Spikevax is already being used in the European Union for people over 18, and in the United States and Canada. Formal approval from the European Commission would be needed to start rolling out the vaccine for teenagers in Europe.

Source: The Star July 23, 2021 17:48 UTC